Skip to main content

Table 1 Current licensed human papillomavirus vaccines

From: Clinical applications and utility of ctDNA in cervical cancer and its precursor lesions: from screening to predictive biomarker

Brand Name

Gardasil

Cervarix

Gardasil 9

Cecoline

Manufacturer

Merck & Co

GlaxoSmithKline

Merck & Co

Xiamen Innovax

Valency

quadrivalent

bivalent

nonavalent

bivalent

VLP Types

HPV6/11/16/18

HPV16/18

HPV6/11/16/18/31/33/45/52/58

HPV16/18

First Licensed

2006

2007

2014

2021

Doses Recommended

2 or 3 doses, depending on age at initiation

2 or 3 doses, depending on age at initiation

2 or 3 doses, depending on age at initiation

2 or 3 doses, depending on age at initiation

Administration

Intramuscular

Intramuscular

Intramuscular

Intramuscular

Expression System

Saccharomyces cerevisiae (Baker’s yeast)

Trichoplusia ni Rix4446 cell using the baculovirus expression vector

Saccharomyces cerevisiae

(Baker’s yeast)

Escherichia coli